EGFR, the epidermal growth factor receptor, is a transmembrane protein that regulates cell growth and division. Mutations or overexpression can produce aberrant signaling, uncontrolled proliferation, and tumor growth, making EGFR a drug-discovery target. section 8.1.1
Computational EGFR drug discovery uses:
- Tyrosine kinase inhibitors to block EGFR signaling and inhibit cancer-cell growth. section 8.1.1
- Curated EGFR kinase bioactivities from ChEMBL-derived Kinodata for predictive modeling. section 8.1.1
- pIC50 as the modeling target: the negative logarithm of IC50, where higher values indicate greater potency. section 8.1.1
EGFR activity modeling
A practical dataset contains 7,287 curated EGFR kinase bioactivities. These measurements can support training a model to predict compound pIC50, helping prioritize molecules expected to inhibit EGFR more potently. section 8.1.1
Figure 8.2 Map of human protein kinases, i.e., the Manning kinome tree, clustered based on sequence similarity into eight major groups [3].

Use the kinome tree to place EGFR within human protein kinases clustered by sequence similarity. section 8.1.1
